Add to ORKGAt last count, global pharmaceutical spending exceeded $750 billion. Unlike most medical products and services, many pharmaceuticals are sold at a price that greatly exceeds marginal cost. AIDS medicines that retail for over $10,000 per person per year in the United States can be produced generically at a marginal cost of less than $150. Patents and other related IP rights create these significant gaps between marginal cost and retail price, generating many billions of dollars in profits (patent rents) for companies
Prescription drug prices in the United States are notoriously higher than in other high-income count...
High drug prices are creating serious health and fiscal problems in the United States to...
In their Original Investigation published in a recent issue of JAMAInternal Medicine, Prasad and Mai...
At last count, global pharmaceutical spending exceeded $750 billion. Unlike most medical products a...
Drug prices are uniquely susceptible to radical price reductions through generic competition. Patent...
The pharmaceutical industry worldwide is a rapidly burgeoning industry contributing to growth of gro...
<div><p>Pharmaceutical sales exceed $850 billion a year, of which 84% are accounted for by brand dru...
In 2019, the record for the most expensive drug was broken at US$2.1 million per patient. The high c...
This paper quantifies the relationship between market size and innovation in the pharmaceutical indu...
This article discusses how pharmaceutical innovation achieves remarkable improvements in human healt...
Rising drug prices are placing an ever larger burden on family budgets and the economy. The Center f...
Context. Recent public outcry has highlighted the rising cost of prescription drugs worldwide, which...
Context. Recent public outcry has highlighted the rising cost of prescription drugs worldwide, which...
Access to affordable prescription drug is the critical mass of any meaningful public health policy. ...
A public economics framework is used to consider how pharmaceuticals should be priced when at least ...
Prescription drug prices in the United States are notoriously higher than in other high-income count...
High drug prices are creating serious health and fiscal problems in the United States to...
In their Original Investigation published in a recent issue of JAMAInternal Medicine, Prasad and Mai...
At last count, global pharmaceutical spending exceeded $750 billion. Unlike most medical products a...
Drug prices are uniquely susceptible to radical price reductions through generic competition. Patent...
The pharmaceutical industry worldwide is a rapidly burgeoning industry contributing to growth of gro...
<div><p>Pharmaceutical sales exceed $850 billion a year, of which 84% are accounted for by brand dru...
In 2019, the record for the most expensive drug was broken at US$2.1 million per patient. The high c...
This paper quantifies the relationship between market size and innovation in the pharmaceutical indu...
This article discusses how pharmaceutical innovation achieves remarkable improvements in human healt...
Rising drug prices are placing an ever larger burden on family budgets and the economy. The Center f...
Context. Recent public outcry has highlighted the rising cost of prescription drugs worldwide, which...
Context. Recent public outcry has highlighted the rising cost of prescription drugs worldwide, which...
Access to affordable prescription drug is the critical mass of any meaningful public health policy. ...
A public economics framework is used to consider how pharmaceuticals should be priced when at least ...
Prescription drug prices in the United States are notoriously higher than in other high-income count...
High drug prices are creating serious health and fiscal problems in the United States to...
In their Original Investigation published in a recent issue of JAMAInternal Medicine, Prasad and Mai...